ClearPoint Neuro CLPT Share-Based Payment Award Options Outstanding - Number
Share-Based Payment Award Options Outstanding - Number at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.
The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about ClearPoint Neuro's share-based payment award options outstanding - number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ClearPoint Neuro's share-based payment award options outstanding - number?
- ClearPoint Neuro (CLPT) reported share-based payment award options outstanding - number of 1.2M in Q1 2026.
- How has ClearPoint Neuro's share-based payment award options outstanding - number changed year-over-year?
- ClearPoint Neuro's share-based payment award options outstanding - number decreased by 7.6% year-over-year, from 1.4M to 1.2M.
- What is the long-term trend for ClearPoint Neuro's share-based payment award options outstanding - number?
- Over 5 years (2020 to 2025), ClearPoint Neuro's share-based payment award options outstanding - number has grown at a -6.3% compound annual growth rate (CAGR), from 1.8M to 1.3M.
- What does share-based payment award options outstanding - number mean?
- This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.